Elevance Health Inc (ELV)
Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell
$300.00
Buy
$304.51
$2.24 (+0.75%)
Prices updated at 02 Apr 2026, 23:53 EDT
| Prices minimum 15 mins delay
Prices in USD
Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and Specialty Business, Government Business and Other.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 176,810m | 199,125m | |
| - | - | |
| - | - | |
| - | - | |
| 5,980m | 5,662m | |
| - | - | |
| Sales, General and administrative | - | - |
| Interest expenses | 1,185m | 1,402m |
| Provision for income taxes | 1,933m | 1,049m |
| Operating expenses | - | - |
| Income before taxes | 7,904m | 6,710m |
| Net income available to common shareholders | 5,980m | 5,662m |
| 25.81 | 25.28 | |
| Net interest income | -1,185m | -1,402m |
| Advertising and promotion | - | - |
| Net investment income, net | 472m | 715m |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 25.68 | 25.21 |
| Free cash flow per share | 3.7206 | 16.602 |
| Book value/share | 192.4348 | 199.1311 |
| Debt equity ratio | 0.707201 | 0.701814 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | - | - |
| Current liabilities | - | - |
| Total capital | 70,533m | 74,679m |
| Total debt | 31,232m | 32,046m |
| Total equity | 41,315m | 43,882m |
| Total non current liabilities | - | - |
| Loans | 29,218m | 30,797m |
| Total assets | 116,889m | 121,494m |
| Total liabilities | - | - |
| Cash and cash equivalents | 8,288m | 9,491m |
| Common stock | 227m | 221m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 6,526m | 8,288m |
| Cash dividends paid | -1,508m | -1,529m |
| 4,552m | 3,174m | |
| Investments (gains) losses | -5,167m | -1,344m |
| 8,288m | 9,491m | |
| Net income | - | - |
| 5,808m | 4,290m | |
| -1,256m | -1,116m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.